Novel Rx
The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020. Watch now!
Rheumatology Round-Up with Drs. Kavanaugh & Cush
The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020.
sheila RHEUMarampa
4 years 7 months ago
Tofa for RA by the grp of Dr. Atul Deodhar:
>Tofa(56%) vs. pbo(29.4%)-significant improvement in ASAS20 at wk 16
>Primary & secondary endpts met
>No new safety signals reported
@Rheumnow #ACR20 https://t.co/G9U5cCQU7K
Sebastian E. Sattui MD, MS SattuiSEMD
4 years 7 months ago
#ACR20 Abstracts on #ILD
Rituximab in ILD (all observational)
#1053 ➡️ 47 with CTD-ILD: overall improvement or stability at 36m
#1051 ➡️ 50 with IPAF: >70% stable or improved at 12m
#1047 ➡️ 47 patients CTD-ILD or IPAF: good experience with MMF and RTX
#ACRambassador https://t.co/klfVwIH5b6
The axSpa diagnosis, imaging and treatments: Dr. Lianne Gensler
Dr. Lianne Gensler reviews several SpA abstracts and a session on MRI presented at the 2020 ACR annual meeting. Abstracts reviews: abstract #1883, #2014, #L11 and #2022.
Meral K. El Ramahi, MD MeralElRamahiMD
4 years 7 months ago
Summary of #ACR20 part B:
- The future is bright with many trainees producing great research per Dr. Diane Karen
- Belimumab (phase III) reduced proteinuria, improved renal for, and helped w/ tapering of GC in pts w/ lupus nephritis but more infect in GC group @RheumNow
Dr. Ken Saag - RECIPE Study: MMF with Pegloticase
Dr. Jack Cush interviews Dr. Ken Saag about the benefits of adding mycophenolate to your pegloticase regimen in refractory gout patients.
Flu and Tofacitinib: Dr. Kathryn Dao
Dr. Kathryn Dao reviews abstract L04 at the 2020 ACR annual meeting.
David Liew drdavidliew
4 years 7 months ago
Can you give TCZ for GCA with minimal steroids?
Everyone hates steroids, right?
GUSTO trial: IVMP 500mg x3d +TCZ sc q1w
14/18 achieved clinical remission at 24w (but mean 11w)
13/18 relapse-free
1/18 permanent visual loss
Is that tradeoff worth it?
#ACR20 ABST0515 @RheumNow https://t.co/H9rgSxL6VP
k dao KDAO2011
4 years 7 months ago
Which biologic will you use after MTX and TNF failure for RA pts? #acr20 @rheumnow
Bella Mehta bella_mehta
4 years 7 months ago
Amazing lecture by Dr Jane Salmon for the RRF memorial foundation to honor Dr Shaun Ruddy #ACR20 @HSpecialSurgery @RheumNow the IMPACT study - pregnancy in APS with Certolizumab Therapy https://t.co/A9U11qI7zG
Eric Dein ejdein1
4 years 7 months ago
#ACR20 Abs#L11. Efficacy of TOFA vs PBO in AS. At week 16, %ASAS20 responders 56% v 29% PBO; %ASAS40 40% vs 12%. @RheumNow #ACRBest https://t.co/3Faj64rBjd
David Liew drdavidliew
4 years 7 months ago
Following RITAZAREM, would you use rituximab maintenance for ANCA-associated vasculitis patients (cost aside)? @RheumNow
Robert B Chao, MD doctorRBC
4 years 7 months ago
Improvement of enthesitis US scores consistent with bDMARD initiation/change
1⃣MASEI and OMERACT scores improved at 3 mo/6mo
2⃣Associated with clinical activity outcomes
@RheumNow #ACR20 Abs#1552 https://t.co/qnSEBaXrJo
David Liew drdavidliew
4 years 7 months ago
RITZAREM
(RTX vs AZA maintenance post RTX induction relapsing AAV)
what happened post-study?
After #ACR19, hope RTX confers ongoing benefit
Answer: no. Same decline
Is 1g q4m dosing not justified?
Does that mean RTX needs to be continued, and in whom?
#ACR20 ABST2052 @RheumNow https://t.co/tldGqca8xC
Poster Hall